Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:02 2024-09-13 EDT			5-day change	1st Jan Change
115.86 ^USD	+0.53%		-1.68%	+6.27%

09-12	Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors	MT
09-11	Merck: positive results for HPV vaccine	CF

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	231,557	206,957	193,588	281,302	276,259	293,683	-	-
Change	-	-10.62%	-6.46%	45.31%	-1.79%	6.31%	-	-
Enterprise Value (EV) ¹	247,453	230,686	218,594	298,801	304,221	314,962	300,662	285,721
Change	-	-6.78%	-5.24%	36.69%	1.81%	3.53%	-4.54%	-4.97%
P/E ratio	23.9x	29.4x	14.9x	19.4x	779x	15.4x	12.8x	11.6x
PBR	9x	8.18x	5.07x	6.12x	7.34x	5.98x	4.72x	3.8x
PEG	-	-1.1x	0.2x	1.7x	-8x	0x	0.6x	1.1x
Capitalization / Revenue	4.94x	4.31x	3.97x	4.75x	4.6x	4.58x	4.29x	4.04x
EV / Revenue	5.28x	4.81x	4.49x	5.04x	5.06x	4.91x	4.39x	3.93x
EV / EBITDA	12.6x	11.2x	10.5x	11.3x	30.2x	11.3x	9.25x	8.21x
EV / EBIT	15.5x	13.6x	12.4x	13.3x	49x	12.7x	10.3x	8.98x
EV / FCF	24.8x	41.4x	25.2x	20.3x	33.3x	16.8x	12.8x	11.1x
FCF Yield	4.03%	2.41%	3.97%	4.92%	3.01%	5.95%	7.82%	9.05%
Dividend per Share ²	2.26	2.48	2.64	2.8	2.96	3.075	3.232	3.392
Rate of return	2.48%	3.03%	3.44%	2.52%	2.72%	2.65%	2.79%	2.93%
EPS ²	3.81	2.78	5.14	5.71	0.14	7.499	9.027	10.02
Distribution rate	59.3%	89.2%	51.4%	49%	2,114%	41%	35.8%	33.9%
Net sales ¹	46,840	47,994	48,704	59,283	60,115	64,122	68,528	72,627
EBITDA ¹	19,572	20,570	20,910	26,431	10,083	27,994	32,493	34,804
EBIT ¹	15,920	16,945	17,696	22,522	6,211	24,730	29,141	31,800
Net income ¹	9,843	7,067	13,049	14,519	365	18,812	22,854	25,668
Net Debt ¹	15,896	23,729	25,006	17,499	27,962	21,279	6,979	-7,962
Reference price ²	90.95	81.80	76.64	110.95	109.02	115.86	115.86	115.86
Nbr of stocks (in thousands)	2,545,984	2,530,034	2,525,944	2,535,396	2,534,023	2,534,809	-	-
Announcement Date	20-02-05	21-02-04	22-02-03	23-02-02	24-02-01	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
MERCK & CO., INC.	15.45x	4.91x	11.25x	+2.65%	294B
ELI LILLY AND COMPANY	59.56x	18.45x	44.86x	+0.56%	832B
NOVO NORDISK A/S	40.44x	14.09x	28.68x	+1.24%	605B
JOHNSON & JOHNSON	22.5x	4.58x	12.96x	+2.83%	398B
ABBVIE INC.	37.8x	7.16x	15.47x	+3.21%	343B
ROCHE HOLDING AG	15.86x	3.76x	9.85x	+3.71%	252B
ASTRAZENECA PLC	28.09x	5.05x	14.99x	+1.98%	243B
NOVARTIS AG	21.48x	4.95x	12.54x	+3.26%	234B
AMGEN INC.	51.21x	6.89x	12.07x	+2.76%	179B
PFIZER, INC.	21.49x	3.69x	10.08x	+5.69%	166B
Average	31.39x	7.35x	17.27x	+2.79%	354.59B
Weighted average by Cap.	36.39x	9.81x	22.94x	+2.21%